Xenon Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Diluted from 2012 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Xenon Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2012 to Q3 2025.
  • Xenon Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 79.2M shares, a 1.7% increase year-over-year.
  • Xenon Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 77.9M shares, a 16.5% increase from 2023.
  • Xenon Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 66.9M shares, a 10.5% increase from 2022.
  • Xenon Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 60.5M shares, a 38.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)

Xenon Pharmaceuticals Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 79.2M +1.32M +1.7% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-03
Q2 2025 79M +1.28M +1.65% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 78.7M +1.09M +1.41% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 77.9M +11M +16.5% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 77.9M +11.9M +18.1% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-03
Q2 2024 77.7M +11.8M +17.9% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 77.6M +11.9M +18.1% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 66.9M +6.35M +10.5% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 66M +537K +0.82% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 65.9M +9.67M +17.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 65.7M +10.9M +19.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 60.5M Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 65.5M +23.2M +54.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 56.2M +14.1M +33.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 54.9M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 42.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 42.1M +7.11M +20.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q2 2020 35M +9.2M +35.7% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-06
Q2 2019 25.8M +11.5M +80.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 25.8M +7.95M +44.6% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-07
Q4 2018 19.4M +1.42M +7.91% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-06
Q3 2018 20.3M +2.3M +12.8% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-06
Q2 2018 14.3M -3.71M -20.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 17.8M -170K -0.95% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 18M +2.51M +16.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 18M +2.74M +18% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 18M +3.58M +24.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 18M +3.58M +24.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 15.5M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 15.3M +970K +6.79% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 14.4M -695K -4.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 14.4M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q3 2015 14.3M +12.2M +574% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-10
Q2 2015 15.1M +13.8M +1023% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q3 2014 2.12M +42.7K +2.05% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 1.35M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q3 2013 2.08M Jul 1, 2013 Sep 30, 2013 10-Q 2014-12-15

Xenon Pharmaceuticals Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 77.9M +11M +16.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 66.9M +6.35M +10.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 60.5M +16.9M +38.8% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 43.6M +9.09M +26.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 34.5M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2018 19.4M +1.42M +7.91% Jan 1, 2018 Dec 31, 2018 10-K 2019-03-06
2017 18M +2.51M +16.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 15.5M +1.21M +8.48% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-07
2015 14.3M +10.3M +260% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 3.96M +1.95M +97.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-08
2013 2.01M +682K +51.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-08
2012 1.33M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.